關鍵數據
7.510今開
7.830最高
9.57K成交量
20.91本益比TTM
6.75本益比動
--股利TTM
0.05%換手率
7.600昨收
7.350最低
72.09K成交額
虧損本益比靜
1.10市淨率
0.00%股息率 TTM
4.08%ROA
22.25052週最高
0.07量比
-20.11M淨利潤
18.77M總股本
0.3693每股盈餘TTM
1.14Beta
5.56%ROE
4.54052週最低
6.32%振幅
71.32%毛利率
144.90M總市值
7.82回報/風險
4.55%風險率

即將為您帶來更多新聞,敬請期待。 。 。
OptimizeRx Corp評分
0.16與上次評分對比預測8.67
財務診斷6.89
技術分析4.07
公司估值6.89
機構認同度7.00
風險評估3.58
分析師評級
買入評級
12.400目標均價
+62.73%漲幅空間
OptimizeRx Corp 最新財報電話會記錄
OptimizeRx (OPRX) 2026 財年第二季法說會:營收下滑 30% 仍重申財測指引
OptimizeRx 2026 年第二季營收下滑 30% 至 2,050 萬美元,管理層則重申其全年營收財測指引介於 9,500 萬美元至 1 億美元。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
OptimizeRx Corp 簡介
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
行業軟體與IT服務
公司代碼OPRX
員工數量106
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Whetstone Capital Advisors, LLC | 8.04% |
|---|
| Weintraub (Michael) | 7.38% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.76% |
|---|
| Royce Investment Partners | 4.73% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 35.58% |
|---|
| Investment Advisor/Hedge Fund | 22.54% |
|---|
| Individual Investor | 12.68% |
|---|
| Hedge Fund | 11.85% |
|---|
常見問題
OptimizeRx Corp(OPRX)的當前股價是多少?
OptimizeRx Corp(OPRX)的當前股價是 7.60。
OptimizeRx Corp 的股票代碼是什麼?
OptimizeRx Corp的股票代碼是OPRX。
OptimizeRx Corp股票的52週最高點是多少?
OptimizeRx Corp股票的52週最高點是22.25。
OptimizeRx Corp股票的52週最低點是多少?
OptimizeRx Corp股票的52週最低點是4.54。
OptimizeRx Corp的市值是142.65M。
現在OptimizeRx Corp(OPRX)的股票是買入、持有還是賣出?
根據分析師評級,OptimizeRx Corp(OPRX)的總體評級為買入,目標價格為12.40。
OptimizeRx Corp(OPRX)股票的每股收益(EPS TTM)是多少
OptimizeRx Corp(OPRX)股票的每股收益(EPS TTM)是0.37。